A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia

2018-09-11

British Journal of Haematology , Volume 185 - Issue 3 p. 623- 627

Additional Metadata
Keywords	acute leukaemia, FLT3, midostaurin, paediatric, relapsed/refractory
Persistent URL	doi.org/10.1111/bjh.15593, hdl.handle.net/1765/116809
Journal	British Journal of Haematology
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Zwaan, M., Soderhall, S., Brethon, B., Luciani, M., Rizzari, C., Stam, R., … Pieters, R. (2018). A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia. British Journal of Haematology, 185(3), 623–627. doi:10.1111/bjh.15593

Publication